Nature Reviews Cancer's 2026 Journal Metrics Score is 24.1, ranking Q1 in Cancer Research and 2 other subfields. Two-year citation average from OpenAlex data, updated August 2026.
Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.
Journal Metrics Score 2026 · 2021–2024 window citedness 31.22.
Not available — there are not enough recent PubMed records with both received and accepted dates.
No journal-level APC is available in the current OpenAlex snapshot. Cost is excluded from scoring.
Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.
Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.
Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.
173 of 460 works · same type, year & subfield
52 works · same type, year & subfield
Below field-year expectation
of 939 topic-associated OpenAlex sources by lifetime output
FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.69, so its typical recent paper runs about 31% below its field benchmark.
37.6% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.
Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.
OpenAlex source records · 2016–2025
460 OpenAlex works · 2021–2024
OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.
Select a MeSH signal to see how much Nature Reviews Cancer publishes on it, from PubMed counts for the last five complete years.
Candidates share at least one OpenAlex subfield (or field, if too few do) with this journal's main research topics, ignoring generic catch-all topics, and are ordered by topic overlap, then current Journal Metrics Score.
* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.
| Category | Quartile |
|---|---|
| Cancer Research | Q1 |
| Molecular Biology | Q1 |
| Oncology | Q1 |
Yes. One of the most-cited journals in Oncology
Yes. By citation data, Nature Reviews Cancer is one of the most-cited journals in Oncology: it ranks #9 of 897 Oncology journals by Journal Metrics Score (top 2%) and is Q1 in Cancer Research and 2 other subfields. Nature Reviews Cancer's 2026 Journal Metrics Score is 24.1. OpenAlex classifies its papers in subfields including Cancer Research, Molecular Biology, and Oncology, so check that your topic fits its scope.
Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.
Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.
2026 Journal Metrics Scores for 13 of 59 Nature journals published by Nature Portfolio, highest score first. Each journal is scored separately; there is no combined score for the Nature family.
Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.
OpenAlex classifies Nature Reviews Cancer's papers in subfields including Cancer Research, Molecular Biology, and Oncology. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.
Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.
Nature Reviews Cancer homepage ↗Use the submit link in Nature Reviews Cancer's author guidelines; Nature Portfolio runs the submission site. Every author usually needs an ORCID iD, and the corresponding author needs an account on the submission site.
OpenAlex has no article processing charge on record. Check the journal website for page charges or an optional open-access fee.
Nature Reviews Cancer does not publish an acceptance rate.
New on PubMed
Type a topic to see the newest PubMed papers from the past week and the big picture of what they found, summarized by Claude on the Pro plan. Get a free weekly email to keep up.
See a demo:GLP-1CRISPRLong COVID
Reviewer Two · coming soon
An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.
See what the report coversYes. By citation data, Nature Reviews Cancer is one of the most-cited journals in Oncology: it ranks #9 of 897 Oncology journals by Journal Metrics Score (top 2%) and is Q1 in Cancer Research and 2 other subfields. Nature Reviews Cancer's 2026 Journal Metrics Score is 24.1. OpenAlex classifies its papers in subfields including Cancer Research, Molecular Biology, and Oncology, so check that your topic fits its scope.
Nature Reviews Cancer's 2026 Journal Metrics Score is 24.1, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.
We have not found an official acceptance rate published by Nature Reviews Cancer or its publisher, and Journal Metrics does not estimate one because submission counts are not public. To judge selectivity, compare Nature Reviews Cancer's quartile and score with similar journals, or ask the editorial office.
Nature Reviews Cancer's best quartile is Q1. By OpenAlex subfield: Q1 in Cancer Research; Q1 in Molecular Biology; Q1 in Oncology. Quartiles rank journals by Journal Metrics Score within each subfield.
No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Nature Reviews Cancer will not match this score exactly. Compare journals using one source at a time.
Comparable journals include Cancer Cell, Trends in Cancer, Cancer Biology & Medicine, and Nature Cancer. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.
Submit online through the link in Nature Reviews Cancer's author guidelines on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter.